Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema

(MedPage Today) -- NEW ORLEANS -- GLP-1 receptor agonists did not significantly affect anti-VEGF treatment frequency in patients with diabetic macular edema (DME), a large retrospective cohort study showed. Over 24 months of follow-up, "no sustained...

No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 13 October →